Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Gene
discovery may help guide breast cancer care 4:54 AM 1/25/2010
Reuters
An abnormality in two genes may make anthracycline chemotherapy drugs used to
fight breast cancer less effective.
...
Venture
capitalists reawaken 4:16 AM 1/22/2010
Boston
Globe
Investment going to biotech firms rose 10 percent from the third to fourth quarter 2009. One
billion dollars going into 108 deals.
...
Genzyme's
Pompe drug review to take six months 12:49 PM 1/21/2010
Reuters
Genzyme Corp said the US FDA has agreed to rule on whether to approve its Pompe
disease drug Lumizyme by June 17.
...
Heart
patients shouldn't use Abbott diet drug-FDA 11:49 AM 1/21/2010
Reuters
European authorities advised doctors to stop prescribing medicines
containing sibutramine which are sold under the names Reductil, Reduxade, and Zelium in Europe and Meridia in
the US.
...
Inspire
Pharma eye drug fails in late-stage trial 8:48 AM 1/21/2010
Reuters
Inspire Pharmaceuticals Inc's late-stage trial on experimental eye drug
Proclaria being developed for the treatment of dry eye disease failed to meet the main goal of efficacy.
...
Roche
drug keeps patients cancer-free longer 5:44 AM 1/21/2010
Reuters
Roche's cancer drug Xeloda enabled elderly patients being treated for colorectal
cancer to live free of the disease longer.
...
Two
MS Pills Show Promise 4:24 AM 1/21/2010
Wall
Street Journal
Two experimental pills for multiple sclerosis made by Novartis and Germany's Merck
KGaA were effective but subjects experienced adverse events that need to be weighed against the benefits.
...
Merck
HIV drug from Schering merger fails trials 2:23 PM 1/20/2010
Reuters
Merck & Co's experimental HIV treatment vicriviroc proved ineffective
in two late-stage studies of patients previously treated with other HIV regimens.
...
Lexicon
diabetes drug shows promise in mid-stage trial 7:13 AM 1/20/2010
Reuters
Lexicon Pharmaceuticals Inc's experimental diabetes drug LX4211 lowered
blood glucose level of type 2 diabetes with improvement in glycemic control.
...
Swiss
warn on flu vaccine with autoimmune disease 5:05 AM 1/20/2010
Reuters
Switzerland's medical regulator recommended that patients with serious
autoimmune diseases not use an H1N1 flu vaccine from Novartis.
...
Glaxo
eyes token profit on malaria vaccine 2:27 AM 1/20/2010
Reuters
GlaxoSmithKline looks for approval by 2012 for its experimental vaccine to prevent
malaria with minimal profit on the product to make it widely available in hard-hit countries.
...
Pfizer
Seeks Partnerships With Chinese Drugmakers 3:38 PM 1/19/2010
Bloomberg
Pfizer Inc is looking for partnerships and acquisitions with Chinese
drugmakers to tap into rising incomes and illness in China. Pfizer expects a wave of consolidation among
Chinese-based drugmakers.
...
Pfizer,
Teva Battle for German Generics Maker 11:48 AM 1/19/2010
Forbes
Pfizer and Teva Pharmaceutical Industries Ltd are locked in a battle for German
generic-drug maker Ratiopharm.
...
Depomed
to conduct another trial for hot flashes drug 9:58 AM 1/19/2010
Reuters
Depomed Inc will conduct an additional late-stage trial for its
experimental drug Serada to treat menopausal hot flashes based on guidance from the US FDA. Serada has shown
disappointing results in two late-stage trials.
...
FDA
warns about counterfeit weight loss drug Alli 7:57 AM 1/19/2010
MSN Money
The US FDA is warning consumers about controlled substance
sibutramine capsules being sold as GlaxoSmithKline's over-the-counter weight loss drug Alli (orlistat).
...
<- Day Earlier | Today's News
|
